Guangdong Zhongsheng Pharmaceutical Co., Ltd. Announcement on the Company's 2025 Profit Distribution Plan
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or major omissions.
I. Deliberation Procedures
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the third meeting of the Ninth Board of Directors on April 27, 2026. The meeting deliberated and approved the "Company's 2025 Profit Distribution Plan" with 9 votes in favor, 0 votes against, and 0 abstentions. This proposal is subject to the approval of the Company's 2025 Shareholders' Meeting.
II. Basic情况 of the 2025 Profit Distribution Plan
(I) Basic Content of this Profit Distribution Plan
-
Distribution Basis: 2025
-
According to the audit by Huaxing Certified Public Accountants (Special General Partnership), the Company's (parent company) net profit in 2025 was RMB 305,400,969.04. In accordance with the "Company Articles of Association" and the "Company Dividend Management System," 10% of the parent company's net profit in 2025, amounting to RMB 30,540,096.90, was set aside as statutory surplus reserve. Adding the undistributed profits from previous years of RMB 429,466,138.72 and deducting the cash dividends of RMB 170,311,295.40 distributed in 2025 (implementing the 2024 distribution plan), the actual distributable profit for this period is RMB 534,015,715.46. As of December 31, 2025, the parent company's capital reserve was RMB 2,025,823,146.45.
-
Considering the Company's profitability prospects, asset status, and market environment, the Company has formulated the 2025 profit distribution plan as follows: Based on the Company's total share capital of 849,930,477 shares as of December 31, 2025, a cash dividend of RMB 2.00 per 10 shares (tax inclusive) will be distributed to all shareholders. No bonus shares will be issued, and no capital reserve will be converted into share capital. The total cash dividend distribution will be RMB 169,986,095.40, and the remaining undistributed profits will be carried forward to the next year.